Merck (MRK) Enterprise Value (2009 - 2026)

Merck (MRK) has reported Enterprise Value for 18 consecutive years, with $309.9 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value rose 63.84% year-over-year to $309.9 billion in Q2 2026; TTM through Jun 2026 was $309.9 billion, a 63.84% increase from a year earlier, with the FY2025 full-year figure at $245.7 billion, up 3.4% from the prior year.
• Enterprise Value was $309.9 billion for Q2 2026 at Merck, up from $291.4 billion in the prior quarter.
• Over five years, Enterprise Value peaked at $328.6 billion in Q1 2024 and troughed at $189.2 billion in Q2 2025.
• A 5-year average of $252.6 billion and a median of $255.9 billion in 2023 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value sank 37.47% in 2025 and soared 63.84% in 2026, its largest moves.
• Over 5 years, Enterprise Value stood at $268.5 billion in 2022, then rose by 0.2% to $269.1 billion in 2023, then slipped by 11.67% to $237.7 billion in 2024, then rose by 3.4% to $245.7 billion in 2025, then rose by 26.13% to $309.9 billion in 2026.
• The last three Enterprise Value figures came in at $309.9 billion (Q2 2026), $291.4 billion (Q1 2026), and $245.7 billion (Q4 2025), per Business Quant data.